| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cb2f4582724860ef8c76817e042309f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y115-01001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-04 |
| filingDate |
2021-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dabd07a1bfa3f88ac37b201bef15bb9b |
| publicationDate |
2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114177280-A |
| titleOfInvention |
Eye lotion containing stable antioxidant enzyme and preparation method thereof |
| abstract |
The invention discloses an eye lotion containing stable antioxidant enzyme and a preparation method thereof, wherein the eye lotion comprises the following components in percentage by weight: 0.001-1.0% of stable antioxidant enzyme; 0.01 to 1.0 percent of sodium hyaluronate; trehalose 0.05-5.0%; 0.2 to 0.4 percent of taurine; 0.001-0.5% of a freshener; 0.1-0.2% of edetate disodium; 0.6 to 0.9 percent of sodium chloride; 0.1 to 0.8 percent of boric acid; 0.01 to 0.2 percent of borax; 0.0001-0.2% of bactericidal preservative; the balance being purified water. The invention can effectively reduce the occurrence of dry eye symptoms and reduce or relieve discomfort caused by dry eye symptoms. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023002088-A1 |
| priorityDate |
2021-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |